BFC Planning’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
BFC Planning's BIIB Position: Q3 2026 in Review
BFC Planning reduced its Biogen (BIIB) stake by 6.7% in Q3 2026, selling an estimated $1.7K and leaving 112 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.
BFC Planning first reported a position in BIIB in Q3 2024 and has held it in 9 quarters since. The position peaked at $140K in Q3 2024. 913 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- BFC Planning held 112 shares of Biogen worth $25.3K as of Q3 2026.
- BFC Planning sold 8 Biogen shares in Q3 2026, an estimated $1.7K.
- Biogen made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1908 holding.
- BFC Planning first reported a position in Biogen in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Biogen position peaked at $140K in Q3 2024.
- 913 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.